收藏本站
热门搜索: A3500  E1910  A1360  25200056  dmem  

Anti-phospho-Neurofilament M (Ser614/Ser619), clone EPR580(2)Y, Rabbit Monoclonal

  • 产品编号:merck-m-04-1061      品牌:millipore       原厂货号:04-1061
  • 产品分类:抗体 > 一抗 > 磷酸化抗体
  • 应用分类:
 
包装:
运保温度: -20ºC
到货周期: 登录后查看
标准价: ¥客户可见
会员价: ¥客户可见
积分: 客户可见
 
登录之后可加入购物车购买,请您 
对比 收藏

运费与支付说明:

1.含干冰类产品有运费;

2. 必须现金付款或有信用额度的会员才可以直接发货,否则需要等待现金付款信息。

描述:

Key Spec Table

Species Reactivity Key Applications Host Format Antibody Type
H IH(P), WB Rb Unpurified Monoclonal Antibody

Description 
Catalogue Number 04-1061
Description Anti-phospho-Neurofilament M (Ser614/Ser619) Antibody, clone EPR580(2)Y, rabbit monoclonal
Background Information Neurofilaments are a type of intermediate filament that serve as major elements of the cytoskeleton supporting the axon cytoplasm. They are the most abundant fibrillar components of the axon, being on average 3-10 times more frequent than axonal microtubules. Neurofilaments (10nm in dia.) are built from three intertwined protofibrils which are themselves composed of two tetrameric protofilament complex of monomeric proteins. The neurofilament triplet proteins (68/70, 160, and 200 kDa) occur in both the central and peripheral nervous system and are usually neuron specific. The 68/70 kDa NF-L protein can self-assemble into a filamentous structure, however the 160 kDa NF-M and 200 kDa NF-H proteins require the presence of the 68/70 kDa NF-L protein to co-assemble. Neuromas, ganglioneuromas, gangliogliomas, ganglioneuroblastomas and neuroblastomas stain positively for neurofilaments. Although typically restricted to neurons, neurofilaments have been detected in paragangliomas and adrenal and extra-adrenal pheochromocytomas. Carcinoids, neuroendocrine carcinomas of the skin, and oat cell carcinomas of the lung also express neurofilaments.

Product Information 
Format Unpurified
Control
  • Untreated and treated SHSY5Y cell lysate.
Presentation Rabbit Monoclonal in buffer containing 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl containing 40% Glycerol, 0.01% sodium azide and 0.05% BSA.

Applications 
Application Please note that this product will not be available for sale after March 15, 2015. Please select one of the other antibodies against this target.
Key Applications
  • Immunohistochemistry (Paraffin)
  • Western Blotting

Biological Information 
Immunogen Phospho-synthetic peptide corresponding to residues surrounding Serine 614/619 of human Neurofilament M.
Epitope Phosphorylated Ser614/Ser619
Clone EPR580(2)Y
Host Rabbit
Specificity This antibody recognizes phosphorylated Ser614/619 of Neurofilament M.
Isotype IgG
Species Reactivity Human
Species Reactivity Note Human
Antibody Type Monoclonal Antibody
Entrez Gene Number
Entrez Gene Summary Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and functionally maintain neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the medium neurofilament protein. This protein is commonly used as a biomarker of neuronal damage. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
Gene Symbol
  • neurofilament-light
  • CMT1F
  • CMT2E
  • FLJ53642
  • NF-L
  • NF68
  • NFL
Modifications
  • Phosphorylation
Purification Method Unpurified
UniProt Number
UniProt Summary FUNCTION: Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber.
SUBUNIT STRUCTURE: Interacts with RGNEF By similarity.
DOMAIN: The extra mass and high charge density that distinguish the neurofilament proteins from all other intermediate filament proteins are due to the tailpiece extensions. This region may form a charged scaffolding structure suitable for interaction with other neuronal components or ions.
PTM: O-glycosylated By similarity.
INVOLVEMENT IN DISEASE: Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734]. CMT1F is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1F is characterized by onset in infancy or childhood (range 1 to 13 years). Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684]. CMT2E is an autosomal dominant form of Charcot-Marie-Tooth disease type 2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.
MISCELLANEOUS: NF-L is the most abundant of the three neurofilament proteins and, as the other nonepithelial intermediate filament proteins, it can form homopolymeric 10-nm filaments.
SEQUENCE SIMILARITIES: Belongs to the intermediate filament family.

Product Usage Statements 
Quality Assurance Evaluated by Western Blot on untreated and treated SHSY5Y cell lysates.
Western Blot Analysis: 1:500 dilution of this antibody was used to detect Neurofilament M in untreated and treated with alkaline phosphatase SHSY5Y cell lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Storage and Shipping Information 
Storage Conditions Stable for 1 year at -20ºC from date of receipt.
Handling Recommendations: Upon first thaw, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.

Packaging Information 
Material Size 100 µL

 


相关图片

说明书

参考文献

本产品可用于的实验

购此产品的人还购买了
最近浏览产品

京ICP备15036693号-2    京公网安备11010802025653    版权所有:北京逸优科技有限公司       0.12

 纠 错